Trial NCT02122003

View at ClinicalTrials.gov 
Org. Study IDs: GP2
Secondary IDs: Istituto Tumori Milano

Last trial update was posted on 2017-11-22

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Metastatic Renal Cell Carcinoma

Stopping Reasons

availability of new and more promising therapeutic agents than expected in the experimentation in question

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID